It is suggested that the VEGF (VEGF165) can bind to NRP1 and then phosphorylate the VEGFR2 to trigger the NRP1/VEGFR2/PI3K/Akt signaling pathways for tumor angiogenesis and invasion. The gene discussed is NRP1; the disease is neoplasm.